pagina di news

Eurofins BioPharma Product Testing vi invita alle giornate di studio: Emergenza ambiente - L'ecotossicologia come strumento di gestione

Eurofins BioPharma Product Testing è lieta di invitarvi alle prossime giornate di studio in programma dal 12 al 14 novembre a Livorno.
Questa sesta edizione sarà suddivisa in due sessioni focalizzandosi sull'importanza dell'ecotossicologia sia nei controlli ordinali che nelle emergenze ambientali.
Queste giornate presentano un'opportunità unica di incontro nel campo ambientale tra il settore pubblico (agenzie e enti di ricerca) e privato.
Eurofins BioPharma Product Testing, presente nel Comitato Scientifico, sarà a vostra disposizione per ogni necessità di approfondimento.

Eurofins BioPharma Product Testing vi invita alle giornate di studio: Emergenza ambiente - L'ecotossicologia come strumento di gestione

Previous news

BioPharma News - 8a edizioneEurofins BioPharma Product Testing Product Hub_European_Pharmaceutical_review_magazineBioPharma News - 7a edizioneBioPharma news - 6a edizionePharma News - 5a edizioneAnnuncio acquisizone CTP LaboratoriesPharma News - 4a edizioneEurofins completes 2012 Laboratory Expansion PlanInternational Leaders Eurofins and MWH Global Complete Strategic Sale and Services Agreement for MWH LaboratoriesPharma News - 3a edizioneEurofins celebrates 25 years of laboratory excellenceEurofins strengthens Asia Pacific footprint with the acquisition of New Zealand Laboratory ServicesPharma News -2° edizioneEurofins Biolab al Simposio AFI 2012Eurofins reinforces leadership in the Brazilian testing marketEurofins reinforces leadership in the Benelux testing marketEurofins raises dividends and objectives for 2012Eurofins Biolab partecipa alla Fiera Expomed 2012Eurofins Enters Into an Agreement to Acquire QTA and a Supply Agreement with BASFPharma News - 1° edizioneEurofins leverages worldwide leadership to benefit the Food & Feed Industry with the launch of its Webinar ServicesEurofins achieved its aggressive objectives with strong earnings growth in 2011Eurofins Doubles Net Profit in the First Nine Months of 2011Eurofins announces successful closing of the transaction for a majority stake in IPL SED Nord and IPL InvestEurofins raises its sales and profit outlook for 2011 at its Annual Investor DayEurofins signs definitive agreement to acquire majority stakes in Institut Pasteur de Lille subsidiaries, IPL SED Nord and IPL InvestNantes Laboratory InaugurationEurofins highlights Asian presence to respond to calls for greater food safety levels in the regionStrong Growth and Operating Leverage Trebles Eurofins’ Net Profit in H1 2011Eurofins concludes loan issuance to further optimize balance sheetEurofins signs an exclusive agreement with the Fondation Institut Pasteur de Lille towards a partnership in the environmental testing fieldEurofins opens state-of-the-art high throughput laboratory for Radioactive Material Analysis in JapanEurofins at the forefront of Full Genome Sequencing for industryEurofins doubles dividends to shareholdersStrong Q1 topline growth provides solid start to 2011Allergen multi-screening in a single analysisEurofins announces successful closing of Lancaster acquisitionEurofins generates strong Free Cash Flows in 2010Eurofins signs agreement to acquire Lancaster Laboratories, IncEurofins reaffirms its mid-term objectivesPharma NEWSDirettiva Attrezzature di lavoroAccreditamento CBTL (Certification Body Test Laboratory)iscrizione sostanzecontrolli micro
Aggiornato da: Daniel Quick
Ultimo aggiornamento: venerdì 4 gennaio 2013